According to reports, the National Cancer Institute (NCI) is nearly 2 years ahead of schedule in sequencing the tumors of 6000 patients called for under the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH), its precision-medicine protocol. What researchers are calling an “unprecedented” rate of patient enrollment, spurred by wide acceptance of the program’s aims by more than 1100 academic cancer centers and community hospitals, led to the shortened time frame.
Lyon J. Cancer Project Speeding Along. JAMA. 2017;318(4):322. doi:10.1001/jama.2017.9616
Customize your JAMA Network experience by selecting one or more topics from the list below.